April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Talha Badar: Venetoclax and Decitabine vs Intensive Chemotherapy for Newly Diagnosed AML
Mar 4, 2025, 10:55

Talha Badar: Venetoclax and Decitabine vs Intensive Chemotherapy for Newly Diagnosed AML

Talha Badar, Hematology/Oncology specialist at Mayo Clinic, shared an article by Jing Lu, et al. on X:

Venetoclax and Decitabine vs Intensive Chemotherapy as Induction for Young Patients with Newly Diagnosed AML.

Venetoclax plus decitabine NOT INFERIOR to intensive chemo in young fit AML.

VEN+DEC was well tolerated.”

Talha Badar: Venetoclax and Decitabine vs Intensive Chemotherapy for Newly Diagnosed AML

Venetoclax and Decitabine vs Intensive Chemotherapy as Induction for Young Patients with Newly Diagnosed AML.

Authors: Jing Lu, et al.

Talha Badar: Venetoclax and Decitabine vs Intensive Chemotherapy for Newly Diagnosed AML